Thus the control of DPP-IV activity is an essential factor in management of type 2 diabetes, and amentoflavone (6), with an IC50 value of 3.9 ± 0.5 μM, was recognized as a potential DPP-IV inhibitor [99]. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.